CBRE vs. Newmark: Which Real Estate Stock Is a Better Buy in 2026?

CBRE posted FY 2025 revenue of nearly $40.6B, up 13.4%, with $1.3B in net income and $1.2B in free cash flow; Newmark grew revenue 20.3% to $3.3B, with $126.2M in net income and $142.6M in free cash flow. The article argues Newmark is the better buy due to its lower valuation (7.8x forward P/E vs. CBRE's 17.6x), faster growth, and a 1.6% dividend yield, while CBRE is pressured by interest-rate sensitivity and recent stock weakness. Overall tone is constructive on both businesses but more favorable toward Newmark as the higher-growth, cheaper stock.

Analysis

The market is implicitly treating this as a growth-vs-value debate, but the bigger setup is a dispersion trade inside commercial real estate. NMRK’s multiple can stay depressed if investors continue to discount its cash conversion because stock-based compensation is materially overstating operating cash flow quality; that makes the dividend look more sustainable than it really is in a slow-down. CBRE, by contrast, is the better “quality compounder” because its larger institutional and recurring services mix should hold up better if transaction activity stalls, even if near-term sentiment remains muted.

The second-order winner is JLL-relative share capture: if clients consolidate mandates toward the most credible counterparty in a weaker macro, CBRE should win the higher-margin advisory and managed services work while smaller brokers lose pricing power. That said, the market is not pricing a straight-line cycle recovery; the real catalyst would be rate cuts or refinancing normalization, which could unlock a 6-12 month re-rating in transaction-sensitive names. Until then, the sector is likely to trade on quarterly revenue acceleration rather than absolute valuation.

The contrarian miss is that NMRK’s apparent cheapness may be a trap if capital returns are being funded before true free cash flow quality is normalized. A 1.6% dividend does little if the underlying business needs continued equity-based comp to retain talent. CBRE is less optically cheap, but its downside is better protected if the economy softens; the stock looks more like an earnings-quality reset than a broken thesis.

Key Decisions for Investors

• Long CBRE / short NMRK as a 3-6 month relative-value pair: thesis is quality cash flow and scale should outperform if CRE remains sluggish; target 10-15% spread widening, stop if NMRK continues >20% revenue growth with no deterioration in cash conversion.
• Sell NMRK upside via covered calls or call spreads into any post-earnings strength over the next 1-2 quarters: valuation is already discounting perfection, while SBC-driven cash quality is the key vulnerability.
• Add CBRE on weakness in the $120s for a 6-12 month horizon: the risk/reward improves if rate-cut odds rise or if management shows transaction stabilization; downside is limited versus higher-beta brokers.
• Avoid chasing the dividend narrative in NMRK until SBC as a % of operating cash flow normalizes below 50%: current yield is not enough compensation for dilution/cash quality risk.